At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 303 enrolled
Drug / intervention
Heparin 1000U/mL +1 moredrug
Likely dose
4% Sodium Citrate with Gentamicin 320 mcg/mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prophylactic Antimicrobial Catheter Lock in Hemodialysis Patients: A Randomized Controlled Clinical Trial
In Brief
A Phase 4 clinical trial evaluating Heparin 1000U/mL and 4% Sodium Citrate with Gentamicin 320 mcg/mL for Bacteremia. Completed, enrolled 303 participants across 1 site.
Detailed Summary
This is a randomized, double blinded, prospective, multicenter, clinical trial of the use of Heparin versus Gentamicin as a pos-dialysis catheter lock solution.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBacteremia
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2003
First PostedDec 2007
Primary CompletionJan 2010
TodayJul 2026
First PostedDec 11, 2007
Enrollment StartSep 1, 2003
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 18.6 years ago
Interventions
Heparin 1000U/mLdrug
A volume sufficient to fill the catheter length will be instilled in both catheter ports post dialysis
4% Sodium Citrate with Gentamicin 320 mcg/mLdrug
A volume sufficient to fill the catheter length will be instilled in both catheter ports post dialysis